Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

British Journal of Cancer
O NehlsB Klump

Abstract

This prospective multicentre phase II study characterises the toxicity and activity of first-line capecitabine and oxaliplatin combination therapy (CAPOX) in advanced biliary system adenocarcinomas. Patients received oxaliplatin (130 mg m(-2), day 1) plus capecitabine (1000 mg m(-2) b.i.d., days 1-14) every 3 weeks. Patients were stratified prospectively into two groups based on location of the primary (gallbladder carcinoma (GBC) or extrahepatic cholangiocarcinoma (ECC) versus intrahepatic mass-forming type cholangiocarcinoma (ICC)). Sixty-five patients were evaluable. The response rate in 47 patients with GBC/ECC was 27% (4% complete responses), and in 23 patients (49%) stable disease (SD) was encountered. In 18 patients with ICC, we observed no objective responses, but 6 patients (33%) had SD. Median survival was 12.8 months (95% CI, 10.0-15.6) for patients with GBC or ECC (GBC: 8.2 months; 95% CI, 4.3-11.7; ECC: 16.8 months; 95% CI, 12.7-20.5), and 5.2 months (95% CI, 0.6-9.8) for ICC patients. In both cohorts, therapy was well tolerated. The most common grade 3-4 toxicity was peripheral sensory neuropathy (11 patients). Our data suggest that the CAPOX regimen is a well-tolerated and active treatment option for advanced ECC...Continue Reading

References

Mar 1, 1989·Controlled Clinical Trials·R Simon
Jan 1, 1996·CA: a Cancer Journal for Clinicians·S L ParkerP A Wingo
Aug 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GlimeliusC Svensson
Mar 13, 1998·Gastroenterology·M A OrtnerH Lochs
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M HejnaM Raderer
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C TournigandM Krulik
Apr 13, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M PenzW Scheithauer
Sep 27, 2001·Annals of Surgery·W R JarnaginL H Blumgart
Mar 8, 2002·Annals of Surgery·Sharon M WeberWilliam R Jarnagin
Jul 11, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T W KimY K Kang
Apr 28, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J J KnoxM J Moore
Aug 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T AndréUNKNOWN GERCOR Group
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer J KnoxMalcolm J Moore
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William R JarnaginBhuvanesh Singh
Jun 9, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F VerderameF Fulfaro
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip A PhilipCharles Erlichman

❮ Previous
Next ❯

Citations

Feb 1, 2014·Japanese Journal of Clinical Oncology·Hirokazu ShojiTakuji Okusaka
Jan 9, 2009·Cancer Cell International·Kawin LeelawatSumalee Tungpradubkul
Sep 25, 2009·World Journal of Gastroenterology : WJG·Jan HarderOliver G Opitz
Jan 1, 2007·Journal of Gastrointestinal Cancer·Renato V LaRoccaBrenda Foreman
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J W Valle
Nov 26, 2015·Japanese Journal of Clinical Oncology·Chandragouda DodagoudarNivedita Patnaik
May 13, 2015·Future Oncology·Bhawna SirohiShailesh V Shrikhande
Oct 1, 2015·Journal of Oncology·Rani KanthanSelliah Chandra Kanthan
Oct 22, 2008·Expert Opinion on Pharmacotherapy·Daniel SeehoferPeter Neuhaus
Feb 5, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jieun LeeMyung Ah Lee
Mar 11, 2017·Expert Opinion on Therapeutic Targets·Jennifer YangGregory B Lesinski
Jun 9, 2016·Arquivos De Gastroenterologia·Rachel RiechelmannGabriel Prolla
Mar 25, 2009·Surgical Oncology Clinics of North America·Fidel David Huitzil-MelendezGhassan K Abou-Alfa
Mar 23, 2017·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Sang Myung Woo
Apr 14, 2010·European Journal of Gastroenterology & Hepatology·Philippe A CassierCatherine Lombard-Bohas
Oct 7, 2008·Journal of Hepato-biliary-pancreatic Surgery·Junji Furuse
Mar 21, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Jorge AdevaJuan W Valle
Apr 28, 2014·Clinical Liver Disease·Saeed Sadeghi, Richard S Finn
Aug 13, 2014·Indian Journal of Surgical Oncology·Bhawna SirohiShailesh V Shrikhande
Jan 23, 2016·Journal of Surgical Oncology·Kerri A SimoJohn B Martinie
May 3, 2013·Current Opinion in Oncology·Mairéad G McNamaraJennifer J Knox
Jan 23, 2016·Cancer·Nestor F EsnaolaCrystal S Denlinger
Jul 28, 2019·Anti-cancer Agents in Medicinal Chemistry·Pratibha PandeyPreeti Bajpai
Dec 12, 2013·F1000Research·Thorvardur R HalfdanarsonMitesh J Borad
Feb 23, 2018·Expert Opinion on Emerging Drugs·Pasquale LombardiFrancesco Leone
Feb 14, 2012·Journal of Gastrointestinal Cancer·Adriana RomitiPaolo Marchetti

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.